NDC 26436-0059-1

This exact product or package identity exists in FDA auxiliary data but is not present in the current primary NDC product table. The package identity is preserved; status rows are reported source observations, not medical conclusions.

Requested NDC: 26436-0059-1
Product root: 26436-0059
Identity scope: Package
Primary current NDC product row: Not present

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
compounder	package	26436-0059	26436-0059-1	COMPOUNDER	Outsourcing facility compounded drug report	2023-1	2026-08-10
compounder	package	26436-0059	26436-0059-1	COMPOUNDER	Outsourcing facility compounded drug report	2022-1	2026-08-10
compounder	package	26436-0059	26436-0059-1	COMPOUNDER	Outsourcing facility compounded drug report	2020-2	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 4 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Reporting period, Snapshot table
Captured / source date	Reporting period	Snapshot	Source SHA-256
2025-08-27 00:00 UTC · source 2025-08-20	2023-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	2022-1	`af8e9b524e63…`	`ca326a94a5e9…`
2025-08-27 00:00 UTC · source 2025-08-20	2020-2	`af8e9b524e63…`	`ca326a94a5e9…`
2025-01-13 04:20 UTC · source 2024-11-20	2023-1	`85f958c8d153…`	`997044a9741e…`

Compounder NDC reports#

Browse the complete compounder directory for this NDC · Browse every current compounder row in the unified auxiliary catalog · browse compounder source captures and parsed snapshots.

Establishment, FEI, Product NDC table
Establishment	FEI	Product NDC	Package NDC	Product	Active ingredients	Reporting period	Normalization
Hybrid Pharma	079665742	26436-0059	26436-0059-1	Tadalafil	20 mg	2023-1	valid
Hybrid Pharma	079665742	26436-0059	26436-0059-1	Tadalafil	20 mg	2022-1	valid
Hybrid Pharma	079665742	26436-0059	26436-0059-1	Tadalafil	20 mg	2020-2	valid
Hybrid Pharma	079665742	26436-0059	26436-0059-2	Tadalafil	20 mg	2025-2	valid
Hybrid Pharma		26436-0059	26436-0059-2	Tadalafil	20 mg	2024-2	valid
Hybrid Pharma	079665742	26436-0059	26436-0059-2	Tadalafil	20 mg	2024-2	valid